Drawing for NEW HORIZONS DIAGNOSTICS

USPTO serial 74633971

NEW HORIZONS DIAGNOSTICS

Reviewed by CopyMark Law Group

Reg. 2009477Status 710
Filing date
Status date
Registration date
Oct 22, 1996
Examiner
LEETZOW, KAREN
Law office
INTENT TO USE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with NEW HORIZONS DIAGNOSTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JONATHAN GRANT

JONATHAN GRANT GRANT PATENT SERVICES2120 L ST NW STE 210WASHINGTON, DC 20037UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001kits primarily comprising reagents and reagent handling components, namely, a matrix for reacting an analyte with labeled antibodies, antigens, binders, receptors, or the like, for detection of analytes from air, water, or soil samples, for scientific or research useSECTION 8 - CANCELLED
005kits primarily comprising reagents and reagent handling components, namely a matrix for reacting an analyte with labeled antibodies, antigens, binders, receptors, or the like for medical or clinical laboratory use; diagnostic reagents for clincial laboratory or medical useSECTION 8 - CANCELLED
042research and development services for new products for clinical, medical, and environmental use performed for othersSECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 31, 2008UNDNUNDELIVERABLE MAIL - NO ACTION TAKEN
Dec 4, 2008MDSCNOTICE OF DESIGN SEARCH CODE MAILED
Jul 28, 2007CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jun 22, 2006CFITCASE FILE IN TICRS
Jul 18, 2003C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 11, 2003815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Apr 11, 2003MAILPAPER RECEIVED
Jul 11, 2002TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 22, 1996R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 30, 1996PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 28, 1996NPUBNOTICE OF PUBLICATION
Apr 28, 1996CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 23, 1996CNEAEXAMINER'S AMENDMENT MAILED
Apr 22, 1996DOCKASSIGNED TO EXAMINER
Jan 26, 1996CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 1995CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 1995DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance